SYSTEMIC SCLEROSIS
Clinical trials for SYSTEMIC SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLEROSIS trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early intervention trial for lung blood vessel disease halted
Disease control TerminatedThis study aimed to see if a drug called riociguat could help people with early-stage pulmonary vascular disease, a condition that can lead to high blood pressure in the lungs. It involved 35 adults with connective tissue diseases like scleroderma who had mildly elevated lung pre…
Matched conditions: SYSTEMIC SCLEROSIS
Phase: PHASE2 • Sponsor: Heidelberg University • Aim: Disease control
Last updated Apr 20, 2026 16:17 UTC
-
Tiny study on drug monitoring in sclerosis ends early
Knowledge-focused TerminatedThis study aimed to see if regularly measuring the amount of a drug called mycophenolic acid in the blood could help doctors better treat skin and lung problems in people with systemic sclerosis. Only 2 people joined before the study was stopped early, so no clear conclusions can…
Matched conditions: SYSTEMIC SCLEROSIS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 17, 2026 02:00 UTC